WHO ICTRP trial
A randomized trial of ingestion methods after acquiring tolerance to medium…
JPRN-UMIN000044897 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000044897 |
|---|---|
| Public title | A randomized trial of ingestion methods after acquiring tolerance to medium doses with oral immunotherapy for patients with severe food allergy |
| Scientific title | A randomized trial of ingestion methods after acquiring tolerance to medium doses with oral immunotherapy for patients with severe food allergy - A randomized trial of oral immunotherapy for children with severe food allergy after acquiring tolerance to medium doses |
| Primary sponsor | National Hospital Organization Sagamihara National Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | food allergy |
| Interventions | Gradual increase of ingestion dose Continuing ingestion of middle doses. |
| Registration date | Jul 19, 2021 |
| Target size | 40 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: